Research Updates

Home » Research Updates

FDA Grants Approval of New Pediatric Glioma Drug to Day One, a Biopharma Co-founded by CureSearch Board Member Dr. Samuel Blackman

Pediatric low-grade glioma (pLGG) is the most common form of pediatric brain cancer. Day One’s OJEMDA™ is the first targeted treatment for pLGG tumors with BRAF fusions and mutations. Last week, on April 23, 2024, Day One Biopharmaceuticals was granted Accelerated […]

FDA Grants Approval of New Pediatric Glioma Drug to Day One, a Biopharma Co-founded by CureSearch Board Member Dr. Samuel Blackman Read More »

CureSearch for Children’s Cancer receives gift to support promising immunotherapy trial

Funds to support cutting-edge immunotherapy trial for pediatric high-grade glioma  Bethesda, MD – February 8, 2020  – CureSearch for Children’s Cancer has received a $1 million gift from the Norcross Family Foundation in support of a first-in-human, phase I/II clinical trial testing

CureSearch for Children’s Cancer receives gift to support promising immunotherapy trial Read More »

Elias Sayour, MD, PhD

From Bench to Bedside in 18 Months: How collaboration landed adolescent-young adult (AYA) patients in a clinical trial

“We were fortunate that CureSearch had just launched their Catapult Award program….It enabled researchers to access up to $2.5M in funding over three years, through a streamlined application process, rather than contending with multiple applications for smaller grants which would have lengthened

From Bench to Bedside in 18 Months: How collaboration landed adolescent-young adult (AYA) patients in a clinical trial Read More »

An Innovative Treatment Approach for DIPG: CureSearch for Children’s Cancer Partners with SebastianStrong Foundation to Fund Promising New Research

Contact: Tiffani CopelandSenior Vice President, Development & CommunicationsCureSearch for Children’s CancerEmail: tiffani.copeland@curesearch.org Bethesda, MD – July 30, 2020 – CureSearch for Children’s Cancer, in partnership with the SebastianStrong Foundation, has awarded a $225,000 Young Investigator grant to Yale Cancer Center’s

An Innovative Treatment Approach for DIPG: CureSearch for Children’s Cancer Partners with SebastianStrong Foundation to Fund Promising New Research Read More »

CureSearch Research Addresses Critical Unmet Need For Safe, Effective Pediatric Brain Cancer Treatments

CureSearch Research Funding DrivesNew Brain Cancer Treatments May is National Brain Tumor Awareness Month, highlighting a critical topic in the childhood cancer community as brain cancers account for 25% of all childhood and adolescent cancer diagnoses. Brain tumor types include medulloblastoma (the most common), high- and low-grade glioma, Primitive

CureSearch Research Addresses Critical Unmet Need For Safe, Effective Pediatric Brain Cancer Treatments Read More »

National Volunteer Week Spotlight: Industry Advisory Council champions pediatric drug development from within

As we work to find new and less-toxic treatments for pediatric cancers, we know that smarter research funding is just one part of the solution. Long-term solutions require a seismic shift in the existing pediatric drug development process. This change

National Volunteer Week Spotlight: Industry Advisory Council champions pediatric drug development from within Read More »

Volunteer Week 2020

Pin It on Pinterest

Scroll to Top